{"id":"https://openalex.org/W2010973471","doi":"https://doi.org/10.1111/j.1365-2249.2008.03814.x","title":"Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study","display_name":"Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study","alternate_titles":[],"publication_year":2008,"publication_date":"2008-11-24","ids":{"openalex":"https://openalex.org/W2010973471","doi":"https://doi.org/10.1111/j.1365-2249.2008.03814.x","mag":"2010973471","pmid":"https://pubmed.ncbi.nlm.nih.gov/19040615","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2675245"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2249.2008.03814.x","doi":"https://doi.org/10.1111/j.1365-2249.2008.03814.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2249.2008.03814.x","pdf_url":null,"source":{"id":"https://openalex.org/S11896317","display_name":"Clinical & Experimental Immunology","issn_l":"0009-9104","issn":["0009-9104","1365-2249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010973471"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2675245/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000786742","display_name":"Sally Thrower","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S L Thrower","raw_affiliation_strings":["Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076162341","display_name":"Louisa Katherine James","orcid":"https://orcid.org/0000-0002-2252-4636","observed_orcids":["https://orcid.org/0000-0002-2252-4636"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L James","raw_affiliation_strings":["King's College London, Department of Immunobiology","King's College London, Department of Immunobiology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College London, Department of Immunobiology","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"King's College London, Department of Immunobiology, and","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":null,"display_name":"W Hall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W Hall","raw_affiliation_strings":["King's College London, Department of Immunobiology","King's College London, Department of Immunobiology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College London, Department of Immunobiology","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"King's College London, Department of Immunobiology, and","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026184433","display_name":"K M Green","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K M Green","raw_affiliation_strings":["Joint Clinical Research Unit, United Bristol Healthcare NHS Trust, Bristol","Joint Clinical Research Unit, United Bristol Healthcare NHS Trust, Bristol, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joint Clinical Research Unit, United Bristol Healthcare NHS Trust, Bristol","institution_ids":[]},{"raw_affiliation_string":"Joint Clinical Research Unit, United Bristol Healthcare NHS Trust, Bristol, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017791907","display_name":"Sefina Arif","orcid":"https://orcid.org/0000-0002-6638-7610","observed_orcids":["https://orcid.org/0000-0002-6638-7610"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S Arif","raw_affiliation_strings":["King's College London, Department of Immunobiology","King's College London, Department of Immunobiology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College London, Department of Immunobiology","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"King's College London, Department of Immunobiology, and","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039485273","display_name":"Jennifer S. Allen","orcid":"https://orcid.org/0000-0002-0311-3444","observed_orcids":["https://orcid.org/0000-0002-0311-3444"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J S Allen","raw_affiliation_strings":["King's College London, Department of Immunobiology","King's College London, Department of Immunobiology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College London, Department of Immunobiology","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"King's College London, Department of Immunobiology, and","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013151434","display_name":"Cassie Van-Krinks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Van-Krinks","raw_affiliation_strings":["King's College London, Department of Immunobiology","King's College London, Department of Immunobiology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College London, Department of Immunobiology","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"King's College London, Department of Immunobiology, and","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021622442","display_name":"Biliana Lozanoska\u2010Ochser","orcid":"https://orcid.org/0000-0002-9347-5886","observed_orcids":["https://orcid.org/0000-0002-9347-5886"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B Lozanoska-Ochser","raw_affiliation_strings":["King's College London, Department of Immunobiology","King's College London, Department of Immunobiology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College London, Department of Immunobiology","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"King's College London, Department of Immunobiology, and","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019919427","display_name":"Liliana G. Petrich de Marquesini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L Marquesini","raw_affiliation_strings":["Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S Brown","raw_affiliation_strings":["Department of Cellular and Molecular Medicine, School of Medical Sciences, University of Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular and Molecular Medicine, School of Medical Sciences, University of Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026334006","display_name":"Florence Susan Wong","orcid":"https://orcid.org/0000-0002-2812-8845","observed_orcids":["https://orcid.org/0000-0002-2812-8845"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F S Wong","raw_affiliation_strings":["Department of Cellular and Molecular Medicine, School of Medical Sciences, University of Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cellular and Molecular Medicine, School of Medical Sciences, University of Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021263113","display_name":"Colin Mark Dayan","orcid":"https://orcid.org/0000-0002-6557-3462","observed_orcids":["https://orcid.org/0000-0002-6557-3462"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"C M Dayan","raw_affiliation_strings":["Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069247087","display_name":"Mark Peakman","orcid":"https://orcid.org/0000-0003-3328-3513","observed_orcids":["https://orcid.org/0000-0003-3328-3513"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Peakman","raw_affiliation_strings":["King's College London, Department of Immunobiology","NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London","King's College London, Department of Immunobiology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College London, Department of Immunobiology","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I200166805"]},{"raw_affiliation_string":"King's College London, Department of Immunobiology and","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5021263113"],"corresponding_institution_ids":["https://openalex.org/I36234482"],"apc_list":{"value":2894,"currency":"GBP","value_usd":3816},"apc_paid":null,"fwci":3.5094,"has_fulltext":false,"cited_by_count":173,"citation_normalized_percentile":{"value":0.9354516,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"155","issue":"2","first_page":"156","last_page":"165"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hla-dr4","display_name":"HLA-DR4","score":0.9350000023841858},{"id":"https://openalex.org/keywords/allergic-hypersensitivity","display_name":"allergic hypersensitivity","score":0.7419999837875366},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.9549999833106995},{"id":"https://openalex.org/keywords/t-cell-suppression","display_name":"T cell suppression","score":0.5540000200271606},{"id":"https://openalex.org/keywords/beta-cell-mass-preservation","display_name":"beta-cell mass preservation","score":0.6169999837875366},{"id":"https://openalex.org/keywords/antigen-specific-immunotherapy","display_name":"antigen-specific immunotherapy","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6805326342582703},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6741020083427429},{"id":"https://openalex.org/C90061646","wikidata":"https://www.wikidata.org/wiki/Q426173","display_name":"Proinsulin","level":3,"score":0.6202638149261475},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.603890061378479},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5466620326042175},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.5168797969818115},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4439978003501892},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4283134937286377},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.42156997323036194},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37817829847335815},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.17082479596138},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.14323696494102478}],"mesh":[{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D004306","descriptor_name":"Dose-Response Relationship, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006684","descriptor_name":"HLA-DR Antigens","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D007271","descriptor_name":"Injections, Intradermal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D007515","descriptor_name":"Islets of Langerhans","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011384","descriptor_name":"Proinsulin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016753","descriptor_name":"Interleukin-10","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D018418","descriptor_name":"Th2 Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D059811","descriptor_name":"HLA-DRB1 Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1111/j.1365-2249.2008.03814.x","doi":"https://doi.org/10.1111/j.1365-2249.2008.03814.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2249.2008.03814.x","pdf_url":null,"source":{"id":"https://openalex.org/S11896317","display_name":"Clinical & Experimental Immunology","issn_l":"0009-9104","issn":["0009-9104","1365-2249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2675245","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2675245/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Exp Immunol","raw_type":"Text"},{"id":"pmid:19040615","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19040615","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental immunology","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/66792c7f-e204-49a0-8d3c-5fa348142820","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/66792c7f-e204-49a0-8d3c-5fa348142820","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrower, S L, James, L, Hall, W, Green, K M, Arif, S, Allen, J S, Van-Krinks, C, Lozanoska-Ochser, B, Marquesini, L, Brown, S, Wong, F S, Dayan, C M & Peakman, M 2009, 'Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study', Clinical and Experimental Immunology, vol. 155, no. 2, pp. 156 - 165. https://doi.org/10.1111/j.1365-2249.2008.03814.x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire_cris_publications/84180d93-3a61-4fab-9b8e-ddc20d741022","doi":null,"is_oa":false,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/84180d93-3a61-4fab-9b8e-ddc20d741022","pdf_url":null,"source":{"id":"https://openalex.org/S4306400895","display_name":"Bristol Research (University of Bristol)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I36234482","host_organization_name":"University of Bristol","host_organization_lineage":["https://openalex.org/I36234482"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrower, SL, James, L, Hall, W, Green, KM, Arif, S, Allen, JS, Van-Krinks, C, Lozanoska-Ochser, B, Marquesini, LG, Brown, S, Wong, FS, Dayan, CM & Peakman, M 2009, 'Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study', Clinical and Experimental Immunology, vol. 155, pp. 156 - 165.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2675245","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2675245/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Exp Immunol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W2776280","https://openalex.org/W614574849","https://openalex.org/W1523933450","https://openalex.org/W1545313141","https://openalex.org/W1979649698","https://openalex.org/W1991664772","https://openalex.org/W1993076646","https://openalex.org/W2007193830","https://openalex.org/W2007307182","https://openalex.org/W2007523022","https://openalex.org/W2012023401","https://openalex.org/W2020690639","https://openalex.org/W2024983647","https://openalex.org/W2039166049","https://openalex.org/W2042321461","https://openalex.org/W2045385822","https://openalex.org/W2048114019","https://openalex.org/W2054698585","https://openalex.org/W2054753856","https://openalex.org/W2059349694","https://openalex.org/W2061120297","https://openalex.org/W2062451762","https://openalex.org/W2065619967","https://openalex.org/W2074463323","https://openalex.org/W2089346000","https://openalex.org/W2097649243","https://openalex.org/W2111196174","https://openalex.org/W2111457140","https://openalex.org/W2119443577","https://openalex.org/W2149513114","https://openalex.org/W2149895222","https://openalex.org/W2166685437"],"related_works":["https://openalex.org/W7135784428","https://openalex.org/W2743949118","https://openalex.org/W1935873314","https://openalex.org/W2808787234","https://openalex.org/W2789070449","https://openalex.org/W3023984174","https://openalex.org/W7216392537","https://openalex.org/W2752082967","https://openalex.org/W4207008708","https://openalex.org/W2981571703"],"abstract_inverted_index":{"Immunotherapeutic":[0],"strategies":[1],"under":[2],"consideration":[3],"for":[4,239],"type":[5,91],"1":[6,92,117],"diabetes":[7,93],"include":[8],"modification":[9],"of":[10,18,45,53,65,70,75,109,142,147,169,178,257,263],"the":[11,29,76,131,156,173,181,194,237],"autoimmune":[12,78],"response":[13,190],"through":[14],"antigen-specific":[15],"routes.":[16],"Administration":[17],"short":[19],"peptides":[20],"representing":[21],"T":[22,150,153,258],"cell":[23,259,265],"epitopes":[24],"targeted":[25],"by":[26],"patients":[27,171,244],"with":[28,89,208],"disease":[30],"represents":[31],"one":[32,177],"approach.":[33],"This":[34,56],"study":[35,59],"evaluated":[36],"safety":[37],"and":[38,73,83,94,118,138,145,200,214,222,261],"mechanistic":[39,84],"outcomes":[40],"during":[41],"first-in-man":[42],"intradermal":[43],"administration":[44],"a":[46],"human":[47],"leucocyte":[48],"antigen-DR4":[49],"(HLA-DR4)-restricted":[50],"peptide":[51,66,110,128,192,211,231,250],"epitope":[52],"proinsulin":[54,249],"(C19-A3).":[55],"randomized,":[57],"open-label":[58],"assessed":[60],"two":[61],"major":[62],"theoretical":[63],"risks":[64],"immunotherapy,":[67],"namely":[68],"induction":[69],"allergic":[71],"hypersensitivity":[72,144],"exacerbation":[74],"proinflammatory":[77,149],"response,":[79],"using":[80],"clinical":[81],"assessment":[82],"assays":[85],"in":[86,111,130,167,172,180,193,212,232,242],"vitro.":[87],"Patients":[88],"long-standing":[90],"HLA-DRB1*0401":[95],"genotype":[96],"received":[97],"30":[98],"microg":[99,105],"(n":[100,106,124],"=":[101,107,125,185,204,226],"18)":[102,108],"or":[103,121],"300":[104],"three":[112],"equal":[113],"doses":[114],"at":[115,164,228],"0,":[116],"2":[119],"months":[120,202,224],"no":[122],"intervention":[123],"12).":[126],"Proinsulin":[127],"immunotherapy":[129,251],"dosing":[132],"regimen":[133],"used":[134],"is":[135],"well":[136],"tolerated":[137],"free":[139],"from":[140],"risk":[141],"systemic":[143],"induction/reactivation":[146],"proinsulin-specific,":[148],"cells.":[151],"Peptide-specific":[152],"cells":[154],"secreting":[155],"immune":[157],"suppressive":[158],"cytokine":[159],"interleukin":[160],"(IL)-10":[161],"were":[162],"observed":[163],"month":[165],"3":[166,201,221],"four":[168],"18":[170],"low-dose":[174,195],"group":[175,196],"(versus":[176],"12":[179],"control":[182],"group;":[183],"P":[184],"not":[186],"significant).":[187],"Mean":[188],"IL-10":[189],"to":[191,217,246],"increased":[197],"between":[198,220],"0":[199],"(P":[203,225],"0.05":[205],"after":[206],"stimulation":[207],"5":[209],"microM":[210,230],"vitro)":[213],"then":[215],"declined":[216],"baseline":[218],"levels":[219],"6":[223],"0.01":[227],"10":[229],"vitro).":[233],"These":[234],"studies":[235],"pave":[236],"way":[238],"future":[240],"investigations":[241],"new-onset":[243],"designed":[245],"examine":[247],"whether":[248],"has":[252],"beneficial":[253],"effects":[254],"on":[255],"markers":[256],"autoimmunity":[260],"preservation":[262],"beta":[264],"mass.":[266]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2010973471","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
